全文获取类型
收费全文 | 472263篇 |
免费 | 49222篇 |
国内免费 | 176篇 |
出版年
2018年 | 4310篇 |
2016年 | 5662篇 |
2015年 | 6911篇 |
2014年 | 8525篇 |
2013年 | 12296篇 |
2012年 | 13676篇 |
2011年 | 14295篇 |
2010年 | 9784篇 |
2009年 | 8799篇 |
2008年 | 12684篇 |
2007年 | 13376篇 |
2006年 | 12529篇 |
2005年 | 11981篇 |
2004年 | 12176篇 |
2003年 | 11849篇 |
2002年 | 11690篇 |
2001年 | 21092篇 |
2000年 | 21363篇 |
1999年 | 16604篇 |
1998年 | 5523篇 |
1997年 | 5649篇 |
1996年 | 5262篇 |
1995年 | 5232篇 |
1994年 | 5128篇 |
1993年 | 5125篇 |
1992年 | 14179篇 |
1991年 | 13860篇 |
1990年 | 13495篇 |
1989年 | 13187篇 |
1988年 | 12341篇 |
1987年 | 11834篇 |
1986年 | 10686篇 |
1985年 | 10892篇 |
1984年 | 8954篇 |
1983年 | 7817篇 |
1982年 | 5852篇 |
1981年 | 5169篇 |
1980年 | 4998篇 |
1979年 | 8838篇 |
1978年 | 6791篇 |
1977年 | 6246篇 |
1976年 | 5756篇 |
1975年 | 6491篇 |
1974年 | 7186篇 |
1973年 | 7168篇 |
1972年 | 6634篇 |
1971年 | 6154篇 |
1970年 | 5296篇 |
1969年 | 5097篇 |
1968年 | 4655篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
11.
12.
Ronac Mamtani James D. Lewis Frank I. Scott Tariq Ahmad David S. Goldberg Jashodeep Datta Yu-Xiao Yang Ben Boursi 《PLoS medicine》2016,13(4)
BackgroundSeveral prior studies have found an association between statin use and reduced risk of colorectal cancer. We hypothesized that these findings may be due to systematic bias and examined the independent association of colorectal cancer risk with statin use, serum cholesterol, and change in cholesterol concentration.ConclusionsAlthough the risk of colorectal cancer was lower in statin users versus nonusers, no difference was observed among those who continued versus discontinued statin therapy, suggesting the potential for indication bias. The association between decreased serum cholesterol and colorectal cancer risk suggests a cholesterol-lowering effect of undiagnosed malignancy. Clinical judgment should be used when considering causes of cholesterol reduction in patients, including those on statin therapy. 相似文献
13.
I. S. Voroshilova 《Biology Bulletin》2016,43(10):1301-1307
This review summarizes published data on the genetic markers used in studies of dreissenide invasions. Causes of genetic differences between local populations are discussed. It is shown that information about the genetic diversity of populations obtained by marker polymorphism analysis should be compared to study invasion directions. 相似文献
14.
L. Crispoltoni S. Porcellati A. M. Del Pino A. Orlacchio G. Coata S. Arnone E. Torlone B. Cappuccini G. C. Di Renzo A. Orlacchio 《Cell biochemistry and function》2014,32(1):87-95
Several epidemiological studies showed that gestational diabetes mellitus is the most frequent metabolic disorder of pregnancy, the pathogenesis of which has yet to be completely clarified. The aim of this study was to investigate the presence and processing of caspase 3 (Casp3) and poly(ADP‐ribose) polymerase 1 (PARP1) in cord blood lymphocytes as markers of apoptosis in relation to glycaemic control during intrauterine life. Our results showed a specific positive correlation between the levels of active Casp3 (17–19 kDa) and the inactive form of PARP1 (89 kDa) in lymphocytes isolated from newborn babies of diabetic women with unbalanced glycaemic control, with a direct correlation between the activation of casp3 and the inactivation of PARP1, that makes lymphocytes unresponsive towards lipopolysaccharide stimulation, highlighting an altered functional response. Besides more studies are required to fully correlate the activation of the apoptotic process during the intrauterine life with the foetal health later in life, our study indicates that a cord blood lymphocyte, an easily accessible source, is informative about the activation of apoptotic stimuli in circulating cells of newborn babies in relation to the glycaemic control reached by the mother during pregnancy. Copyright © 2013 John Wiley & Sons, Ltd. 相似文献
15.
In this article, we discuss molecular mechanisms involved in the evolution of amygdala kindling and the episodic loss of response
to pharmacological treatments during tolerance development. These phenomena allow us to consider how similar principles (in
different neurochemical systems) could account for illness progression, cyclicity, and drug tolerance in affective disorders.
We describe the phenomenon of amygdala-kindled seizures episodically breaking through effective daily pharmacotherapy with
carbamazepine and valproate, suggesting that these observations could reflect the balance of pathological vs compensatory
illness-induced changes in gene expression. Under certain circumstances, amygdala-kindled animals that were initially drug
responsive can develop highly individualized patterns of seizure breakthroughs progressing toward a complete loss of drug
efficacy. This initial drug efficacy may reflect the combination of drug-related exogenous neurochemical mechanisms and illness-induced
endogenous compensatory mechanisms. However, we postulate that when seizures are inhibited, the endogenous illness-induced
adaptations dissipate (the “time-off seizure” effect), leading to the re-emergence of seizures, a re-induction of a new, but
diminished, set of endogenous compensatory mechanisms, and a temporary period of renewed drug efficacy. As this pattern repeats,
an intermittent or cyclic response to the anticonvulsant treatment emerges, leading toward complete drug tolerance.
We also postulate that the cyclic pattern accelerates over time because of both the failure of robust illness-induced endogenous
adaptations to emerge and the progression in pathophysiological mechanisms (mediated by long-lasting changes in gene expression
and their downstream consequences) as a result of repeated occurrences of seizures. In this seizure model, this pattern can
be inhibited and drug responsivity can be temporarily reinstated by several manipulations, including lowering illness drive
(decreasing the stimulation current.), increasing drug dosage, switching to a new drug that does not show crosstolerance to
the original medication, or temporarily discontinuing treatment, allowing the illness to re-emerge in an unmedicated animal.
Each of these variables is discussed in relation to the potential relevance to the emergence, progression, and suppression
of individual patterns of episodic cyclicity in the recurrent affective disorders. A variety of clinical studies are outlined
that specifically test the hypotheses derived from this formulation. Data from animal studies suggest that illness cyclicity
can develop from the relative ratio between primary pathological processes and secondary endogenous adaptations (assisted
by exogenous medications). If this proposition is verified, it further suggests that illness cyclicity is inherent to the
neurobiological processes of episode emergence and amelioration, and one does not need to postulate a separate defect in the
biological clock. The formulation predicts that early and aggressive long-term interventions may be optimal in order to prevent
illness emergence and progression and its associated accumulating neurobiological, vulnerability factors. 相似文献
16.
17.
B Balkau E Eschwège L Papoz J L Richard J R Claude J M Warnet P Ducimetière 《BMJ (Clinical research ed.)》1993,307(6899):295-299
OBJECTIVE--To identify risk factors for all cause mortality according to glucose tolerance status. DESIGN--Cohort study with an average 15.6 years'' follow up. SETTING--Paris, France. SUBJECTS--7166 working men aged 44-55 in 1968-72 in the Paris prospective study cohort, with non-insulin dependent diabetes or known result of two hour 75 g oral glucose tolerance test. MAIN OUTCOME MEASURES--Risk factors for death from all causes. RESULTS--128 men were known to be diabetic, 180 had diabetes diagnosed, and 697 had impaired glucose tolerance diagnosed. Compared with normoglycaemic men the relative risks of death in these groups were 2.0 (95% confidence interval 1.4 to 3.0), 2.7 (2.0 to 3.6), and 1.6 (1.3 to 2.0) respectively. Obesity, smoking, high blood pressure, and high non-esterified fatty acid concentration were risk factors for death in all subjects and were unaffected by glucose tolerance. The risks for fasting and two hour insulin concentrations and mean corpuscular volume were two times higher in known diabetic men than in men not known to be diabetic. Central obesity was significant only in men not known to be diabetic (1.6 (1.4 to 1.9)). In known diabetic men a two hour glucose concentration higher than 11.1 mmol/l carried a relative risk of death of 3.8 (1.4 to 9.4). CONCLUSIONS--Diabetic men have similar risk factors for early mortality to other men but are at higher risk from hyperinsulinaemia, hyperglycaemia, and high mean corpuscular volume. 相似文献
18.
I Young 《BMJ (Clinical research ed.)》1993,307(6910):1008
19.
20.